Description
Technical & Manufacturing Relevance:
Clinically well-established probiotic yeast used for management and prevention of antibiotic-associated diarrhea, traveler’s diarrhea, IBS support, and gut microbiota balance. Naturally resistant to antibiotics, making it suitable for co-administration with antibiotic therapies. Good stability compared to bacterial probiotics, but moisture and heat control remain critical.
Applicable Dosage Forms:
Capsules, sachets, powders, sticks, pediatric formulations, synbiotic blends
Pharmacopoeial / Quality Notes:
Strain identification mandatory (commonly CNCM I-745); CFU count must be guaranteed at end of shelf life. Tested for absence of pathogenic yeasts/bacteria, heavy metals, and microbial purity as per pharmacopeial and probiotic guidelines. Moisture-barrier packaging recommended.
Animal-origin Declaration:
Non-animal origin; microbial fermentation–derived and vegetarian/vegan suitable
Manufacturing Support:
Available for contract manufacturing, private/white labeling, customized probiotic and synbiotic formulations, complete regulatory documentation (CoA, MSDS, strain dossier), and export-ready compliance for resale and distribution worldwide
